Serum Anti-Mullerian Hormone Levels Might Indicate Premenopausal Endometrial Lesions

被引:0
|
作者
Yao, Yingsha [1 ]
Shi, Liujing [1 ]
Zhu, Xiaoming [1 ,2 ]
机构
[1] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou 310006, Peoples R China
[2] Zhejiang Univ, Womens Hosp, Sch Med, Key Lab Womens Reprod Hlth Zhejiang Prov, Hangzhou 310006, Peoples R China
关键词
polycystic ovary syndrome; endometrial proliferative lesions; anti-Mullerian hormone; threshold value; regression model; POLYCYSTIC-OVARY-SYNDROME; CANCER STATISTICS; RISK; HYPERPLASIA; ULTRASOUND; PREDICTION; CONSENSUS; CRITERIA; CA125; HE-4;
D O I
10.3390/diagnostics13213301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Endometrial proliferative lesions (EPL) usually refer to endometrial hyperplasia (EH) and endometrial cancer (EC). Among patients with premenopausal EPL who wish to preserve their fertility, only those with EH and early-stage EC have the possibility to undergo fertility preservation therapy. However, there is currently a lack of specific and reliable screening criteria and models for identifying these patients. Methods: This study utilized a retrospective diagnostic study design. The training set included medical record information that met the criteria between August 2017 and October 2022, while the validation set consisted of medical record information that met the criteria from November 2022 to May 2023. The endometrial pathological test served as the gold standard. The serum anti-Mullerian hormone (AMH) level before endometrial sampling and a regression model were employed to predict EPL. Results: The study included a total of 1209 patients with PCOS (1119 in the control group and 90 in the endometrial proliferative lesion group) and 5366 women without PCOS (5249 in the control group and 117 in the proliferative lesion group). In the case of PCOS patients aged 20-39 years, the most effective screening threshold for AMH was found to be a serum AMH level of <= 5.39 ng/mL. The model used for this group was logit(p) = -2.562 - 0.430 x AMH + 0.127 x BMI + 1.512 x hypertension + 0.956 x diabetes -1.145 x regular menstruation. On the other hand, for non-PCOS women aged 20-39 years, the optimal screening threshold for AMH was determined to be a serum AMH value of <= 2.18 ng/mL. The model used for this group was logit(p) = -3.778 - 0.823 x AMH + 0.176 x BMI + 2.660 x diabetes -1.527 x regular menstruation -1.117 x dysmenorrhea. It is important to note that all of these findings have successfully passed internal verification. Conclusion: For PCOS and non-PCOS women aged 20-39 years, the serum AMH test and related multiple regression models were obtained for the warning of EPL.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Anti-Mullerian Hormone in Female Reproduction
    di Clemente, Nathalie
    Racine, Chrystele
    Pierre, Alice
    Taieb, Joelle
    ENDOCRINE REVIEWS, 2021, 42 (06) : 753 - 782
  • [22] Serum anti-Mullerian hormone levels decrease after endometriosis surgery
    Kim, Young-Joo
    Cha, Sun-Wha
    Kim, Hye-Ok
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 37 (03) : 342 - 346
  • [23] Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women
    Stracquadanio, M.
    Ciotta, L.
    Palumbo, M. A.
    GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (03) : 223 - 228
  • [24] Sibutramine administration decreases serum anti-Mullerian hormone (AMH) levels in women with polycystic ovary syndrome
    Vosnakis, Christos
    Georgopoulos, Neoklis A.
    Armeni, Anastasia K.
    Papadakis, Efstathios
    Roupas, Nikolaos D.
    Katsikis, Ilias
    Panidis, Dimitrios
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 163 (02) : 185 - 189
  • [25] The relationship between serum anti-Mullerian hormone levels and the follicular arrest for women with polycystic ovary syndrome
    Li, Jian
    Li, Rong
    Yu, Hua
    Zhao, Shuyun
    Yu, Yang
    Qiao, Jie
    SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2015, 61 (02) : 103 - 109
  • [26] IVF outcomes of women with discrepancies between age and serum anti-Mullerian hormone levels
    Zhang, Bingqian
    Meng, Yueru
    Jiang, Xiao
    Liu, Chao
    Zhang, Huihui
    Cui, Linlin
    Chen, Zi-Jiang
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2019, 17 (1)
  • [27] Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome
    Wong, Ho Yan Queenie
    Li, Hang Wun Raymond
    Lam, Karen Siu Ling
    Tam, Sidney
    Shek, Chi Chung
    Lee, Chi Yan Vivian
    Yeung, William Shu Biu
    Ho, Pak Chung
    Ng, Ernest Hung Yu
    CLINICAL ENDOCRINOLOGY, 2018, 89 (05) : 634 - 641
  • [28] The utility of measuring anti-Mullerian hormone in predicting menopause
    Aydogan, B.
    Mirkin, S.
    CLIMACTERIC, 2015, 18 (06) : 777 - 789
  • [29] Serum Anti-Mullerian Hormone Levels Were Negatively Associated With Body Fat Percentage in PCOS Patients
    Luo, Er
    Zhang, Jinxiao
    Song, Jiahui
    Feng, Di
    Meng, Yaxin
    Jiang, Hongyu
    Li, Da
    Fang, Yuanyuan
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [30] Anti-Mullerian Hormone Expression in Endometrial Cancer Tissue
    Gowkielewicz, Marek
    Lipka, Aleksandra
    Piotrowska, Aleksandra
    Szadurska-Noga, Marta
    Nowakowski, Jacek J.
    Dziegiel, Piotr
    Majewski, Mariusz Krzysztof
    Jozwik, Marcin
    Majewska, Marta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06)